Showing results (111-120 of 1,059) with videos related to

Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|May 22, 2024
Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practiceHugo Geerts, Silke Bergeler, Mike Walker, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 17, 2024
Recruiting a prospective community cohort to study Alzheimer's disease and structural and social determinants of health among adults racialized as Black: The ARCHES cohortAlexis I B Walker, Jean-Francois Trani, Christian F Banks, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 25, 2023
Correction to "The (in)visible Brazilians: A perspective review on the need for brain health and dementia research with Brazilian immigrants in the United States"
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2019
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medicationsDavid M Kern, M Soledad Cepeda, Simon Lovestone, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe dosesMaria Z Kounnas, Murat S Durakoglugil, Joachim Herz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
Comparison of cholinesterase inhibitor safety in real-world practiceGreg Carney, Ken Bassett, James M Wright, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trialGene L Bowman, Hiroko H Dodge, Sophie Guyonnet, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 1, 2020
Sensing a problem: Proof of concept for characterizing and predicting agitationWan-Tai M Au-Yeung, Lyndsey Miller, Zachary Beattie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 1, 2020
CSF glucose tracks regional tau progression based on Alzheimer's disease risk factorsColleen Pappas, Brandon S Klinedinst, Scott Le, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I studyJanine Kutzsche, Dagmar Jürgens, Antje Willuweit, et al.
Pageof 106